PLX icon

Protalix BioTherapeutics

65 hedge funds and large institutions have $6.58M invested in Protalix BioTherapeutics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+3
Holders Change %
+4.84%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
12
Reduced
16
Closed
23
Calls
$125K
Puts
$5K
Net Calls
+$120K
Net Calls Change
+$75K
Name Holding Trade Value Shares
Change
Shares
Change %
AllianceBernstein
76
AllianceBernstein
Tennessee
-$29.5K -23,400 Closed
Wells Fargo
77
Wells Fargo
California
-$29.4K -23,369 Closed
SG Americas Securities
78
SG Americas Securities
New York
-$27K -21,467 Closed
T. Rowe Price Associates
79
T. Rowe Price Associates
Maryland
-$21K -15,982 Closed
ProShare Advisors
80
ProShare Advisors
Maryland
-$15.3K -12,147 Closed
California State Teachers Retirement System (CalSTRS)
81
California State Teachers Retirement System (CalSTRS)
California
-$8.56K -6,797 Closed
Legal & General Group
82
Legal & General Group
United Kingdom
-$6.75K -5,359 Closed
AIP
83
Ameritas Investment Partners
Nebraska
-$5.84K -4,638 Closed
TC
84
Truvestments Capital
Florida
-$4.89K -3,880 Closed
AB
85
Amalgamated Bank
New York
-$2K -1,894 Closed
N
86
Natixis
France
-$126 -100 Closed
AWM
87
Avior Wealth Management
Nebraska
-$11 -9 Closed